- Schoolboy invents early test for pancreatic cancer that killed Steve Jobs
- Jack Andraka’s new test detects pancreatic cancer earlier than any other
- Deadly disease currently kills 19 out of 20 within five years
- He claims his invention could raise survival rates to ‘close to 100 per cent’
A 15-year-old schoolboy could save millions of lives after he invented a new, low-cost test that can detect the early stages of a deadly form of cancer.
Jack Andraka from Crownsville, Maryland, developed a simple dip-stick test for levels of mesothelin, a biomarker for early stage pancreatic cancer found in blood and urine.
It promises to revolutionise treatment of the disease, which currently kills 19 out of 20 sufferers after five years – largely because its so difficult to detect until its final stages.
Jack’s invention, for which he was last month awarded the grand prize of $75,000 in scholarship funds at the 2012 Intel Science Fair, means that patients now have a simple method to detect pancreatic cancer before it becomes invasive.
His novel patent-pending sensor has proved to be 28 times faster, 28 times less expensive, and over 100 times more sensitive than current tests.
Thanks to the test, pancreatic cancer patients could now get an early earning to seek medical help when it still has a chance of working, which could, he claims, potentially bump up survival rates to ‘close to 100 per cent’. Continue reading →